Journal updates

  • Q&A with the Editor in Chief

    In this Q&A, Prof Olga Golubnitschaja, Editor-in-Chief, joins us to discuss the developments in the field of 3P medicine and the impact that the EPMA Journal has had over the last decade. 


    Prof Golubnitschaja also shares with us her latest research and thoughts on how 3PM will continue to develop in the coming years.

    © mrPliskin / Getty Images / iStock
  • Featured article: Making a complex dental care tailored to the person

    Oral cavity health is pivotal for prediction and prevention of associated pathologies. Inadequately provided oral health services in populations are caused by multi-factorial deficits. 


    In this study, researchers investigated a variety of factors to determine key parameters for patient stratification considering person-tailored approach in a complex dental care in the population. 

    Making a complex dental care tailored to the person
  • Featured article: Challenging management of severe chronic disorders in acute pandemic situation

    Chronic liver disease management is a comprehensive approach requiring multi-professional expertise and well-orchestrated healthcare measures thoroughly organized by responsible medical units. The corresponding multi-faceted chain of healthcare events is likely to be severely disturbed or even temporarily broken under the force majeure conditions such as global pandemics. Consequently, the chronic liver disease is highly representative for the management of any severe chronic disorder under lasting pandemics with unprecedented numbers of acutely diseased persons who, together with the chronically sick patient cohorts, have to be treated using the given capacity of healthcare systems with their limited resources.


    In this study, researchers explored the potential negative impact of the SARS CoV-2 outbreak on the quality of the advanced chronic liver disease (ACLD) management by considering two well-classified parameters: (1) the continuity of the patient registrations and (2) the level of mortality rates, comparing pre-COVID-19 statistics with these under the current pandemic in Slovak Republic.

    New Content Item
  • Featured article: Prostate cancer management

    Societies around the world are facing the paradoxal epidemic development of prostate cancer (PCa) as a non-communicable disease. PCa is the most frequently diagnosed cancer for men in several countries such as the USA. Permanently improving diagnostics and treatments in the PCa management causes an impressive divergence between, on one hand, permanently increasing numbers of diagnosed PCa cases and, on the other hand, stable or even slightly decreasing mortality rates. 


    The article summarises knowledge accumulated in regard to the PCa-relevant non-modifiable and modifiable risk factors, highlights current deficits in PCa managements and presents innovative solutions in the context of predictive, preventive and personalised (3P) medicine.

  • 2019 Journal Metrics

    SCImago Journal Rank (SJR) measures weighted citations received by the journal. In 2019, the SJR for EPMA Journal is 1.263, placing it in the 1st quartile of the 'Health Policy' category, with particularly high level of international collaboration amongst researchers.


    Scopus CiteSore measures average citations received per document published. The 2019 CiteSore for EPMA Journal is 7.700. This ranks the journal as 8th in the 'Health Policy' category, within the 96th percentile.


    Source-Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal’s subject field. The 2019 SNIP for EPMA Journal is 1.469.

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.